References
- FerlayJShinHRBrayFEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
- ParkinDMBrayFFerlayJPisaniPGlobal cancer statistics, 2002CA Cancer J Clin20055527410815761078
- LuoRHZhaoZXZhouXYGaoZLYaoJLRisk factors for primary liver carcinoma in Chinese populationWorld J Gastroenterol200511284431443416038048
- YangJDKimWRCoelhoRCirrhosis is present in most patients with hepatitis B and hepatocellular carcinomaClin Gastroenterol Hepatol201191647020831903
- LiapiEGeschwindJFTranscatheter and ablative therapeutic approaches for solid malignanciesJ Clin Oncol200725897898617350947
- JangJWChoiJYBaeSHTransarterial chemolipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinomaJ Hepatol200441342743515336446
- JangJWChoiJYBaeSHA randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolizationHepatology200643223324016440357
- JangJWKwonJHYouCRRisk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinomaAntivir Ther201116796997722024512
- LiawYFKaoJHPiratvisuthTAsian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateHepatol Int20126353156126201469
- Ministry of Health of the People’s Republic of ChinaUpdated standards for the diagnosis and treatment of primary liver cancerZhonghua Gan Zang Bing Za Zhi201220419426 Chinese23230592
- LokASMcMahonBJChronic hepatitis BHepatology200745250753917256718